Patients with granulomatosis with polyangiitis whose autoantibodies are against the myeloperoxidase protein (MPO) have increased disease activity at diagnosis but…
Articles by Patricia Inacio, PhD
Patients with ANCA-associated vasculitis using an immunosuppressive therapy may be at risk of late-onset pneumonia caused by opportunistic Pneumocystis jirovecii infection, a…
Men with ANCA-associated vasculitis (AAV) presenting kidney inflammation are more likely than women to progress into end-stage renal disease,…
In patients with ANCA-associated vasculitis (AAV), the reappearance of ANCA autoantibodies may work as a biomarker for predicting relapse,…
Patients with ANCA-associated vasculitis (AAV) who develop pulmonary bleeding as a result of their condition fare significantly better if…
Isotretinoin, a medication used to treat severe acne, may in rare instances lead to ANCA-associated vasculitis (AAV), according to…
The U.S. Food and Drug Administration has approved two automated diagnostic tests that AESKU.Group developed for ANCA-associated vasculitis. AESKU used its …
Patients with ANCA-associated vasculitis carry a threefold higher risk for cardiovascular disease, and a eightfold greater risk for cerebrovascular accidents, compared…
Patients with ANCA-associated vasculitis (AAV) have a higher prevalence of thyroid disease than the general population, a single-center retrospective…
Chest manifestations and disease activity at diagnosis may help predict the risk of infections during hospital stays in patients with anti-neutrophil cytoplasmic…